Archive · Business Recorder
Pakistan’s Ferozsons to manufacture US-based Gilead's HIV prevention drug
Ferozsons Laboratories Limited (FEROZ), a Pakistani pharmaceutical company, has joined a select group of global manufacturers in Gilead Sciences’ expanded royalty-free licensing programme for its investigational once-yearly lenacapavir for HIV prevention, covering 120 high-incidence countries. The listed pharma disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Thursday. “The agreement, expanded from the existing twice-yearly lenacapavir for HIV prevention access strategy, covers 120 high-incidence countries (which are primarily low- and lower- middle-income) and wil...
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Business Recorder →